Overall, in this study, we reveal that SLC35D3 is involved in obesity via NOTCH1 signaling, and low adipose SLC35D3 expression in obesity might be a therapeutic target for obesity and associated metabolic disorders. This evidence concerns the gene NOTCH1 and obesity due to melanocortin 4 receptor deficiency.